CLAUDIA VELEZ: Open Payments
NPI 1568812238 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 7 companies in 2025. Trend: 2023 $1,120 · 2024 $650 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $112 |
| PFIZER INC. | 3 | $49 |
| Novo Nordisk Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Radius Health, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: XIFAXAN, Ozempic, MOUNJARO, Veozah, Tymlos, ELIQUIS, Kerendia, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
